Marketing for Early-Stage Pharmaceutical & Biotechnology Companies
If you are a discovery or preclinical stage pharmaceutical or biotech company, you most likely aren’t marketing to doctors and patients. You’re marketing to people specialized in life science. You may be positioning yourself for a partnership, licensing, or acquisition deal with a larger pharma / biotech company. You might be looking for venture capital. Either way, does it make sense to work with a marketing agency who specializes in marketing commercialized products to a very different audience of doctors and patients?
The alternative is to work with a marketing agency founded by scientists with both laboratory and marketing experience who can sell your science to people who talk science. That’s what BioBM is. Since 2010 we have only worked with companies marketing themselves to scientific audiences.
Is your audience scientific? If so, BioBM will help you communicate with them more effectively so you get your desired outcome. Step one? Have a conversation with BioBM.
The preclinical-stage pharmaceutical company etiraRx was looking to develop a website to tout their early-stage portfolio of cancer therapeutics to potential investors and partners. To accompany it and capture the interest and attention of their audiences, they wanted a video which showcased their lead candidate’s mechanism of action (in short, disrupting protein folding in cancer cells at the endoplasmic reticulum). BioBM created a 25-second 3D animation using a geometric style which included a lot of negative space, allowing it to be used as a background or foreground video. The simple but striking website was also designed and developed by BioBM.